Business Context and Reporting Period
This Form 6-K filing by Gold Fields Limited, a South African incorporated entity, covers the month of June 2011. The report discloses compliance with JSE Limited Listings Requirements regarding the granting of equity-based compensation to directors of major subsidiaries.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on securities transactions and executive compensation details.
Material Changes and Transactions
On March 1, 2011, the company granted Share Appreciation Rights (SARS) and Performance Vesting Restricted Shares (PVRS) to three directors. These offers were accepted on June 2 and June 7, 2011.
- MD Fleischer: Granted 9,113 SARS (strike price R119.15) and 10,425 PVRS (strike price Nil).
- TW Rowland: Granted 5,963 SARS (strike price R119.15) and 6,113 PVRS (strike price Nil).
- KFL Moabelo: Granted 6,488 SARS (strike price R119.15) and 6,638 PVRS (strike price Nil).
SARS vest after three years with a three-year exercise window thereafter. PVRS vest after three years contingent on performance criteria, with settlement ranging from 0% to 300% of the conditional award.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. The primary risk disclosed relates to the dilution potential of the equity grants and the performance conditions attached to the PVRS. Settlement of both SARS and PVRS may be made in shares or cash at the company's discretion.
Investor Verification Checklist
- Verify the impact of the granted SARS and PVRS on total share count and potential dilution.
- Confirm the specific performance criteria required to settle the PVRS awards.
- Review the company's cash position to assess the ability to settle awards in cash if elected.
- Check subsequent filings for the actual vesting and exercise of these instruments.